Pre-Emptive Pharmacogenetic Testing in Clinical Practice

被引：0
|
作者：
Swen, Jesse J. [1 ]
机构：
[1] Leiden Univ, Med Ctr, Leiden, Netherlands
来源：
EUROPEAN JOURNAL OF HUMAN GENETICS | 2022年 / 30卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
E06.1
引用
收藏
页码：19 / 19
页数：1
相关论文
共 50 条
  • [1] Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing
    Duarte, Julio D.
    Dalton, Rachel
    Elchynski, Amanda L.
    Smith, D. Max
    Cicali, Emily J.
    Lee, James C.
    Duong, Benjamin Q.
    Petry, Natasha J.
    Aquilante, Christina L.
    Beitelshees, Amber L.
    Empey, Philip E.
    Johnson, Julie A.
    Obeng, Aniwaa Owusu
    Pasternak, Amy L.
    Pratt, Victoria M.
    Ramsey, Laura B.
    Tuteja, Sony
    Van Driest, Sara L.
    Wiisanen, Kristin
    Hicks, J. Kevin
    Cavallari, Larisa H.
    GENETICS IN MEDICINE, 2021, 23 (12) : 2335 - 2341
  • [2] Clinical use of pre-emptive pharmacogenetic programmes
    Penas-LLedo, Eva
    LLerena, Adrian
    LANCET, 2023, 401 (10374): : 320 - 321
  • [3] Implementing pre-emptive pharmacogenetic screening into clinical routine
    Forsstrom, J.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 : S85 - S85
  • [4] Temporary Like Achilles: Pre-emptive germline pharmacogenetic testing
    Damkier, Per
    Andersen, Michael Asger
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2023, 133 (04) : 397 - 399
  • [5] Reply to: Temporary Like Achilles: Pre-emptive germline pharmacogenetic testing
    Guchelaar, Henk-Jan
    Swen, Jesse
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2023, 133 (04) : 400 - 401
  • [6] A prognostic model based on readily available clinical data enriched a pre-emptive pharmacogenetic testing program
    Schildcrout, Jonathan S.
    Shi, Yaping
    Danciu, Ioana
    Bowton, Erica
    Field, Julie R.
    Pulley, Jill M.
    Basford, Melissa A.
    Gregg, William
    Cowan, James D.
    Harrell, Frank E., Jr.
    Roden, Dan M.
    Peterson, Josh F.
    Denny, Joshua C.
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2016, 72 : 107 - 115
  • [7] The Case for Pre-Emptive Pharmacogenetic Screening in South Africa
    Hurrell, Tracey
    Naidoo, Jerolen
    Masimirembwa, Collen
    Scholefield, Janine
    JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (01):
  • [8] Obviously nine believers: Actionable germline genetic variants for pre-emptive pharmacogenetic testing
    Damkier, Per
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2020, 126 (01) : 5 - 6
  • [9] Estimation of Impact of Implementing Pre-emptive Pharmacogenetic Testing in Hospital Treated Patients in Finland
    Kulla, N.
    Cajanus, K.
    Kyto, V
    Niemi, M.
    Tornio, A.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (SUPPL 1) : S101 - S101
  • [10] Pre-emptive pharmacogenetic testing in the acute hospital setting: a cross-sectional study
    McDermott, John H.
    Burke, Kerry
    Fullerton, Neil
    O'Sullivan, James
    Alex, Aleina
    Ingham, Amy
    Sharma, Videha
    Godfrey, Nicola
    Odudu, Aghogho
    Syed, Tania
    Stevens, Andrew
    Beynon, Rhys
    Greaves, Nicholas
    Akam, Daniel
    Mirza, Selman
    Wilson, Paul
    Wright, Stuart
    Payne, Katherine
    Newman, William G.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2024,
12345